|
EQS Total Voting Rights Announcement: Marinomed Biotech AG
/ Total Voting Rights Announcement
Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
30.09.2024 / 10:00 CET/CEST
Total Voting Rights Announcement according to Article 135, Section 1 of the BörseG transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Marinomed Biotech AG herewith announces pursuant to Sec. 135 Para. 1 of the Stock Exchange Act, that due to the resolution on the capital increase of September 18, 2024, the total number of voting rights as at the end of September 2024 has increased to 1,694,583 voting rights, and the Company's new share capital amounts to EUR 1,694,583. The change in the total number voting rights took effect upon entry in the commercial register on September 28, 2024.
30.09.2024 CET/CEST
|
